# Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic Ascites

> **NCT04785755** · PHASE2 · COMPLETED · sponsor: **Hala Abd EL-Tawab Ibrahim Radwan** · enrollment: 90 (actual)

## Conditions studied

- Hepatic Ascites

## Interventions

- **DRUG:** Oral standard diuretics therapy
- **DRUG:** Hypertonic saline solution
- **DRUG:** Etilefrine

## Key facts

- **NCT ID:** NCT04785755
- **Lead sponsor:** Hala Abd EL-Tawab Ibrahim Radwan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-30
- **Primary completion:** 2020-03-21
- **Final completion:** 2020-04-30
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2021-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04785755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04785755, "Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic Ascites". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04785755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*